Diabetes News You Can Use

Metformin helps prevent diabetes development in at-risk patients

A study in Diabetes Care showed that adults at risk for diabetes who took 850 mg of metformin twice daily had lower diabetes incidence rates over 15 years, compared with those on placebo. Researchers used a cohort of 3,234 patients from the Diabetes Prevention Program and the Diabetes Prevention Program Outcomes Study and found that metformin also led to a 41% reduced diabetes incidence among women who previously had gestational diabetes.Healio (free registration)/Endocrine Today (3/18)

Study examines changes in screening among adults without diabetes

Seventy-eight percent of 12,772 adults without diabetes, ages 45 or older, underwent diabetes screening at least once over three years, with glucose test used 86% of the time and A1C 14% of the time, according to a study in Diabetes Care. Researchers also found that A1C testing is increasingly used for screening and is associated with higher rates of diabetes diagnosis, treatment and referral.Physician’s Briefing/HealthDay News (2/11)

Diabetes is most common cause of ED visits for older patients

Diabetes accounted for 25.8% of all emergency department visits made by older patients, followed by chronic pulmonary disease, renal disease, congestive heart failure and peripheral vascular disease, according to a study published in the Annals of Emergency Medicine. Researchers conducted a multicenter retrospective cohort study involving 1,259,809 patients, aged at least 65, and found frequent ED visits were tied to injury-related events and pain-related diagnoses.

Healio (free registration)/Endocrine Today (2/3)

Research finds lack of CV risk factor control in diabetes

A study in Diabetes, Obesity and Metabolism showed that only 21.6% of diabetes patients achieved composite control of all four risk factor targets for atherosclerotic cardiovascular disease — A1C, blood pressure, LDL cholesterol and not smoking — with women having a lower overall risk factor control rate at 18.6%, compared with men at 23.6%. Researchers analyzed data from the Diabetes Collaborative Registry involving 74,393 patients and found that 85.2% of patients were nonsmokers, 73.6% met individual A1C targets, 69% achieved BP targets and 48.6% met LDL cholesterol targets.

Endocrinology Advisor (2/1)

Weight fluctuations tied to worse diabetes outcomes, study finds

Researchers analyzed data from the FDA Adverse Event Reporting System between April 2005 and September 2017 and found that older diabetes patients who used GLP-1 receptor agonists were not at an increased risk for diabetic retinopathy. The findings in Diabetes Care revealed that 263 of the 389 GLP-1 receptor agonist-related DR events were associated with exenatide, 82 with liraglutide, 28 with dulaglutide and 16 with albiglutide. Endocrinology Advisor (1/1)

Upcoming Events

Diabetes and Metabolism Seminar Series

2019 Diabetes Day

05-29-2019 - 9:45 am
850 Republican St
Seattle, WA 98109

Fellows of the Year Presentation

Rising Star Presentation

Keynote Address

Trainee Poster Session

Seminar location: SLU Campus/Orin Smith Auditorium

Other Events